Brown To Speak At Minorities-In-Bioscience Luncheon

April 03, 1998

SAN FRANCISCO -- San Francisco Mayor Willie Brown will be the guest speaker at the Fourth Annual Minority Student Opportunity Luncheon at the Experimental Biology Meeting Wednesday, April 22, 1998. U.S. Surgeon General David Satcher, who had been scheduled as a speaker, was forced to cancel.

The meeting, designed to encourage minority students into biomedical research, is part of the Experimental Biology meeting in San Francisco. It is scheduled for noon at the ANA Motel, Metropolitan III, beginning at noon.

Students from the Bay Area will get to meet some of the premier researchers in the country to learn about opportunities. The aim of the program is to set at least 200 minority college students on a career path in research. Minority groups are greatly underrepresented in medical science research. According to federal figures the proportion of researchers from minority groups is strikingly lower than their percentage in the overall population. Although the number of minority graduates of medical schools has increased in the last decade, the percentage of those students going into research and teaching has not.

This will be the fourth annual luncheon held in conjunction with the meeting of the Federation of American Societies for Experimental Biology, which this year will draw some 14,000 biomedical researchers to the Moscone center. The convention, one of the largest science meetings in the world, runs from April 18-22.

The luncheon is co-sponsored by the American Association of Anatomists, the experimental biology federation, and the National Institutes of Health. The American Association of Anatomists is one of America's oldet and most prestigious professional scientific organizations, its members having earned seven Nobel Prizes and more than 100 memberships in the National Academy of Sciences.

American Association of Anatomists

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to